Skip to content

Inspection Record

Absolute Pharmacy LLC — FDA 483 Findings

US FDAInspected 2016-05-18Published 2024-01-17 6 findingsAseptic processing and sterility assuranceDeviation, CAPA, and investigationStability and storage

View the regulator's official source The source document is always the basis for judgement.

Findings

1Aseptic processing and sterility assurance

Aseptic processing areas are deficient regarding the system for monitoring environmental conditions, cleaning and disinfecting the room and equipment to produce aseptic conditions.

2Aseptic processing and sterility assurance

Procedures designed to prevent microbiological contamination of drug products purporting to be sterile do not include validation ofthe sterilization process.

3Deviation, CAPA, and investigation

Any unexplained discrepancy or the failure of a batch and any of its components to meet any of its specifications shall be thoroughly investigated, whether or not the batch has already been distributed.

4Aseptic processing and sterility assurance

Procedures designed to prevent microbiological contamination ofdrug products purporting to be sterile are not established, written, and followed.

5Aseptic processing and sterility assurance

For each batch of drug product purporting to be sterile and/or pyrogen-free, there shall be appropriate laboratory testing to determine conformance to such requirements.

6Stability and storage

Results of stability testing are not used in determining expiration dates.

Similar findings at other companies

GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.

A record as of the US FDA document published on 2024-01-17. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

Other records for this company

Absolute Pharmacy LLC findings history — including this company's other documentsAll US FDA findings US FDA documents, 2024 Go to Findings search
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.